It is also reported that the overexpression of lncRNA GAS5 in the PBMCs of patients with RA can activate the AMP-activated protein kinase (AMPK) pathway, negatively regulate the expression of IL-6 and IL-17, and alleviate RA disease activity (94). Here, GAS5 is linked to rheumatoid arthritis.